AMUNDSENHot Line 2Lipids
AMUNDSEN
Evolocumab before percutaneous coronary intervention for acute myocardial infarction
Presenting authorGilles MontalescotInterventional / Structural Cardiology · Maastricht University Medical CentreGilles Montalescot is Professor of Cardiology at Pitié-Salpêtrière Hospital and Sorbonne University in Paris, France. He is an interventional cardiologist and president of the ACTION group. His research focuses on acute coronary syndromes, antiplatelet therapies, and myocardial revascularization guidelines.
Overview
Evolocumab before percutaneous coronary intervention for acute myocardial infarction
Discussion
Expert reaction lands here the moment AMUNDSEN reports.
Key Points
- Results pending.
Cite This Study
Gilles Montalescot (Thu,) studied this question.